Biodegradable airway stents in infants – Potential life-threatening pitfalls
Introduction
Severe tracheobronchial obstruction is rare in early childhood and is generally caused by non-malignant lesions. The most frequent anomalies are malacia and stenosis, either congenital or acquired [1]. Surgical intervention is challenging due to the specific anatomical situation, the small size, thin, soft and vulnerable tissues of the pediatric airways. Stenting is an important therapeutic modality for the maintenance of the lumen patency through primary application, or through an external approach with reconstructive surgery [2]. Silicone and metallic stents have been widely used [3], [4]. Unfortunately, several complications are associated with them. Silicone stents might tend to migrate and disturb airway mucociliary clearance. Metal stents are hard to remove once embedded in the tracheal because of hyperplastic granulation [3], [4], [5]. To avoid these complications new biodegradable stents have been developed [6]. They are completely dissolvable after a predetermined period of time or by an enzymatic triggering mechanism, so theoretically their removal is not required. Biodegradable stents have been used experimentally for airway stenting since 1998. These stents were originally designed for alimentary tract, but after encouraging animal studies [7] they were recently utilized for treatment of benign airway stenosis [8], [9]. Considering these advantages we started our study; however, our controversial first experiences revealed an unexpected life-threatening complication.
Section snippets
Method
In 2012–2013 five Self-expanding SX-Ella Biodegradable polydioxanone stent (Ella-CS, Hradec Kralove, Czech Republic, www.ellacs.eu) in three young children were applied in two tertiary care centres in Hungary, Department of Otorhinolaryngology Head and Neck Surgery, University of Szeged and Heim Pál Children's Hospital. The sizes of the stents applied were decided on the basis of measurements made on computer tomography and trachea-bronchography.
The compressed stents loaded in their delivery
Discussion
The main causes of serious tracheobronchial obstructions are the following: congenital malacia, postsurgery stricture and airway compression caused by enlarged great vessels [1], [4]. Montgomery first described the use of silicone T-tubes in the adult trachea in 1965 [11]. Airway stent insertion has been extremely useful in treating neonates and infants with severe localized airway narrowing since the 1990s [1], [2], [3], [4], [5]. An ideal airway stent should have the following properties: (I)
Conclusions
Polydioxanone stents may offer an alternative to metallic or silastic stents for collapse or external compression of the trachea. They may avoid the need for permanent stenting and allow subsequent growth of the airway. However, large decaying fragments mean a potential risk especially in the small size pediatric airway. The fragmentation of the stent, which generally starts in the 4–6 postoperative weeks, may create large sharp pieces. These may be anchored to the mucosa and covered by crust
References (20)
- et al.
Tracheobronchial stenting for the treatment of airway obstruction
J. Pediatr. Surg.
(1998) - et al.
Airway stents
Ann. Thorac. Surg.
(2008) - et al.
First experience with biodegradable airways stents in children
Ann. Thorac. Surg.
(2011) - et al.
Novel biodegradable polydioxanone stents in a rabbit airway model
J. Thorac. Cardiovasc Surg.
(2012) - et al.
A shape memory stent for tracheobronchomalacia in children: an experimental and clinical study
J. Pediatr. Surg.
(1997) - et al.
Study of the hydrolytic degradation of polydioxanone PPDX
Polym. Degrad. Stab.
(2000) - et al.
Comparison of tissue reactions in the tracheal mucosa surrounding a bioabsorbable and silicone airway stents
Ann. Thorac. Surg.
(1998) - et al.
Partial cricotracheal resection for pediatric subglottic stenosis: a single institution's experience in 60 cases
Eur. Arch. Otorhinolaryngol.
(2003) - et al.
Tracheobronchial obstruction: follow-up study of 100 children treated with airway stenting
Eur. J. Cardiothorac. Surg.
(2014) - et al.
The role of airway stenting in pediatric tracheobronchial obstruction
Eur. J. Cardiothorac. Surg.
(2008)
Cited by (39)
Bronchial Remodeling Following Airway Stenting in Pediatric Patients With Tracheobronchial and Congenital Heart Disease
2023, Journal of the Society for Cardiovascular Angiography and InterventionsA novel ex vivo tracheobronchomalacia model for airway stent testing and in vivo model refinement
2023, Journal of Thoracic and Cardiovascular SurgeryCongenital airway anomalies
2021, Seminars in Pediatric SurgeryResorbable airway splint, stents, and 3D reconstruction and printing of the airway in tracheobronchomalacia
2021, Seminars in Pediatric SurgeryCitation Excerpt :Degradation is complete, so removing it is not necessary, enabling airway growth (Fig. 1(A) and (B)).6,26–28 Given its resorbable nature, multiple procedures may be needed to maintain airway patency.6,19,26,29,30 Complications such as coughing or swallowing the stent as a foreign body27 are usually considered mild.
Bronchial stenting in infants with severe bronchomalacia: Technique and outcomes
2021, International Journal of Pediatric OtorhinolaryngologyPreclinical evaluation of a pediatric airway stent for tracheobronchomalacia
2021, Journal of Thoracic and Cardiovascular Surgery